Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer, HDAC5, HDAC7, HDAC8 and the tag heme.
Shares A Study of CTD402 in T-ALL/LBL Patients, A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex), ARID5B, BAK1 and the tag heme.
Shares Unicar-Therapy, Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies, TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies, IMPDH1 and the tag heme.
Shares A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations, IELSG32, MATRix/IELSG43, Primary CNS lymphoma and the tag umbrella.
Shares Quantitative imaging biomarkers (RECIST, PERCIST, SUV, ADC) and the tag umbrella.
Shares Obecabtagene autoleucel, Burkitt lymphoma, CD19, Hodgkin lymphoma and the tag umbrella.
The same record for scripts and assistants; checked 2026-09-04. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.